Tracing the roots of 3-[2-(3,5-Dimethyl-2-Oxocyclohexyl)-2-Hydroxyethyl]Pentanediamide takes us back to the growing curiosity of organic chemists working through the late 20th century. Synthetic chemists, looking for new building blocks for advanced polymers and specialty chemicals, often stumbled across intermediates like these not just by aiming for them directly, but by pursuing reactions combining alpha,beta-unsaturated ketones and selective diamides. Back then, complex cyclohexanone derivatives were not as readily available, so research teams pieced them together through laborious multi-step reactions. The rise of academically-driven combinatorial chemistry and mechanistic studies brought a sharper focus to functionalized amides and substituted cyclohexyl frameworks. Libraries of related compounds have been cited in journals whenever industries sought durable, water-loving additives or tuneable molecular scaffolds for drug design and catalysis. As the synthetic methods improved, so did the appreciation for molecules like this — especially those that bind specific ions, interact with metals, or change properties with slight structural tweaks.
At its core, 3-[2-(3,5-Dimethyl-2-Oxocyclohexyl)-2-Hydroxyethyl]Pentanediamide represents a branched, functionalized amide that bridges the gap between traditional linear diamides and more complex, cage-like macrocycles. The backbone has a 3,5-dimethyl-2-oxocyclohexyl ring, which provides some rigidity yet enough flexibility in terms of chemical modification. The pendant 2-hydroxyethyl group gives this molecule potential grip for hydrogen-bonding, solubility tuning, and biological tagging. Since amides occur everywhere from proteins to industrial resins, a derivative like this raises eyebrows as a possible linking agent, complexing ligand, or additive in composite materials. I remember colleagues often hunting for molecules with just that balance: polar enough to mix with water, robust enough to handle processing conditions, and with a structural complexity offering something beyond simple acetylation or methylation.
Anyone handling this compound will run into its moderate to high melting point, reflecting the stable amide bonds and the impact of cyclohexyl substitution on crystal packing. In solution, the hydroxyethyl side chain pulls it somewhat into hydrophilic territory, although the cyclohexanone ring and methyl groups maintain enough nonpolar character that solubility in pure water remains limited. Solubility in alcohols and polar aprotic solvents like dimethyl sulfoxide tends to be more forgiving, which makes sense given the balance between the hydrophobic and hydrophilic components. The chemical stability stems mainly from the saturated cyclohexane ring and the resonance-stabilized amide groups, offering fair resistance to standard hydrolysis at room temperature. Anyone tempted to push it through harsh acidic or basic conditions should watch for amide bond cleavage and ring rearrangement. In my experience, compounds like this stand up well to moderate heat and atmospheric oxygen, but shouldn't be left unprotected in rough conditions or in presence of strong oxidizers.
Labeling for this compound usually centers on its dual amide groups, cyclohexyl ring, and secondary alcohol motif. Analytical chemists in the lab track it using proton and carbon NMR, confirming the shift patterns for methyl groups on the cyclohexanone and the ethylene bridge to the amide. Quality control focuses on purity above 98%, minimal residual solvents, and defined melting point range. Some suppliers highlight the need for storage at cool temperatures, out of direct sunlight, to preserve long-term stability. From handling similar compounds, I always looked for tight caps, proper safety labeling acknowledging skin sensitization or irritative hazards, and checked the expiration date if planning sensitive downstream chemistry.
Industrial and lab syntheses both rely on stepwise addition, starting with cyclohexanone functionalization. 3,5-dimethyl substitution usually comes through Friedel-Crafts acylation or alkylation, followed by introduction of a 2-oxo group if not already present. The hydroxyethyl chain gets grafted via nucleophilic addition, often using a protected amino alcohol to prevent side reactions. Coupling with pentanediamide requires precise control over reaction stoichiometry, temperature, and choice of activating agents—carbodiimides like EDC or DCC often do the trick, especially if minimizing unwanted oligomerization or side amidation. This is not the sort of process that runs one-pot in a single beaker, and purification can drag on, particularly when byproducts stubbornly co-elute on silica or reverse-phase columns. Experience with high-vacuum drying, careful fraction collection, and patient recrystallization helps keep yields respectable.
There’s real opportunity in tuning the side groups on this molecule. The hydroxyethyl side can serve as a launchpad for esterification, etherification, or even click chemistry. Attaching a fluorescent probe or a chelating group isn’t out of reach. Amidic nitrogens open doors for N-alkylation or N-acylation, which can tilt its solubility, reactivity, or biological compatibility. Reductive amination of the cyclohexanone, or further alkylation of the methyl groups, brings new performance in selectivity or binding if targeting specific receptors or metal ions. In research groups pushing boundaries in functionalized small molecules and ligands, such modifications guarantee a wealth of permutations, keeping synthetic chemists and analytical teams busy.
In the literature, this compound can pop up under systematic IUPAC labels, or under inventory codes that reference its structural motifs. It’s not unusual to spot names that emphasize the pentanediamide backbone or the cyclohexyl-ketone connection. Anyone fishing through CAS registries or chemical supplier catalogs should keep an eye out for alternate spellings or simplified descriptors highlighting only the dominant functional groups. Chemical communication gets complicated when older papers use shorthand, but the ring, amide, and hydroxyethyl components usually offer clear signposts.
The main safety angle involves the amide groups, which have been known in broader studies to possess skin and eye irritant properties. Hydroxyethyl groups may boost absorption if there’s a breach in gloves. Anyone accustomed to handling aromatic or aliphatic amides heads straight to the fume hood, and I’ve always taught junior researchers to double-glove, minimize direct contact, and to avoid inhalation of fine dust during weighing or transfer. Waste disposal follows the same lines as other organic amides, avoiding drains and favoring collection for controlled incineration. Documentation should cover local regulatory touchpoints, and emergency showers and eyewash stations become non-negotiable in any lab with open bottles of this kind of molecule.
Materials scientists and formulation chemists keep an eye out for advanced amides with water-compatible side chains: not just for resins or adhesives, but in surfactant R&D, hybrid polymer blends, and stable emulsifiers. Drug discovery has toyed with related amides as possible scaffold fragments, especially when chasing new antibiotics or enzyme inhibitors. In my time collaborating with med-chem teams, related structures occasionally showed up as hits in binding assays or as fragments in larger natural-product-inspired syntheses. Some environment-facing sectors examine these molecules as binders for specific pollutants, hoping for selectivity against heavy metals or emerging contaminants. With its modular build, this compound holds promise wherever tailored hydrophilicity and chemical toughness are needed.
Teams big and small keep experimenting with ring-substituted diamides, finding fresh tweaks to boost performance or unlock new abilities. The push toward greener synthesis has spurred interest in catalytic, one-step processes that make such compounds with fewer byproducts and less waste. As more labs opt for high-throughput screens, libraries containing close cousins of this molecule flood combinatorial sets, targeting not just bench-scale experiments but real-world deployment in smart coatings and biomedical supplies. Multidisciplinary teams draw from computational chemistry, prediction of drug-likeness, and automated analytics to shorten development cycles. Some of the most compelling work I’ve followed leverages machine learning to predict new uses, flipping through virtual catalogs of functionalized amides, many of which share this compound’s backbone as their starting point.
As with most advanced amides, investigation into this compound’s bioactivity and toxicity still sits in the early stages. Structurally, it shares features with non-toxic commercial polyamides, but the cyclohexanone ring and hydroxyethyl residue introduce a level of unpredictability for both acute and chronic exposure. In vitro tests tend to focus on skin cell viability, absorption rates, and the potential for mutagenicity. So far, initial data suggest low acute toxicity in mammalian systems, as expected from a non-aromatic amide platform, but repeated-exposure and environmental fate studies remain rare. Until more robust data rolls in, any widespread use in food-contact applications or consumer-facing products stays on hold. I’ve seen plenty of molecules delayed at this stage, emphasizing just how much due diligence and regulatory compliance matter even when innovative chemical structures look promising.
Looking ahead, this molecule sets the stage for advances in specialty materials, selective catalysis, and even drug delivery platforms. If green chemistry pushes yield higher, and researchers chart the toxicity landscape thoroughly, avenues to broaden application could open further. The unique blend of functionality ensures keen interest from those working to extend the properties of classic nylons or surfactants into the next generation of sustainable, performance-oriented substances. For early-career scientists, tracking the progress and learning from both successes and setbacks in research on compounds like this offers real-world lessons in innovation, rigorous safety culture, and the value of building out complete data profiles before scaling up or commercializing any new chemical entity.
Most people don’t go digging through the names of industrial chemicals unless they work in research, manufacturing, or pharmaceuticals. I've spent years around labs and factories, so spotted this one cropping up more often: 3-[2-(3,5-Dimethyl-2-Oxocyclohexyl)-2-Hydroxyethyl]pentanediamide. It's not just chemical jargon — this compound steps into the spotlight as a specialty intermediate, especially in the pharmaceutical world.
Drug companies chase efficiency and safety every day, and this amide has become a solid team player. Its structure isn’t an accident. The unique arrangement supports important steps in synthesizing certain medications. In particular, you see it helping build the backbone of compounds that fight infection or mediate inflammation — both areas where precision saves lives.
Drug manufacturing is a balancing act. Take it from someone who once watched a miscalculated reaction yield a useless pile of byproduct. The fine points of a molecule’s structure can mean the difference between life-saving medicine and wasted effort. The presence of a cyclohexyl group, the hydroxy attachment, and that diamide chain all stabilize transition states, improve solubility, and offer predictable behavior during chemical reactions.
Researchers appreciate the flexibility in its design. If a manufacturer aims to develop new compounds for testing against resistant bacteria, these characteristics speed up the rounds of synthesis. In the real world, that can bring effective medicine to patients faster.
The reliability of specialty chemicals makes all the difference at scale. Nobody in a pharmaceutical facility wants inconsistent results. That’s why the quality protocols for producing this amide match the highest industry expectations. Manufacturers put it through rigorous purity checks, stability tests, and monitor for trace contaminants that could derail the next step in a complex synthesis.
Industry regulators keep close watch. The FDA and EMA push for transparency and evidence, so supply sources must document their practices and maintain clean records. Workers expect to handle chemicals safely, and companies invest in proper training and ventilation. Based on what I’ve seen, a small slip can mean downtime, regulatory headaches, or worse — so attention to proper chemical handling always gets top priority.
Cost pressure never leaves. Research groups and plant managers have to battle with budgets and weigh environmental impact. Greener chemistry keeps gaining traction, so there’s a growing push to refine synthesis pathways and waste treatment for these intermediates. Groups like the ACS Green Chemistry Institute find ways to make production safer for people and lighter on the planet. If more manufacturers join in, the downstream health and safety gains could go far beyond one plant or product line.
Every year, specialty intermediates like this help accelerate the discovery of drugs that improve lives. Chemical engineering might feel abstract, but real people end up relying on these building blocks, whether it be for antibiotics, pain relief, or future therapies we don’t see coming yet. The effort put into developing, sourcing, and safely using compounds like this pays off across the whole supply chain — right down to the person picking up a prescription at the pharmacy.
My years in the science beat have taught me something important: clarity is rare when a new chemical pops up. 3-[2-(3,5-Dimethyl-2-Oxocyclohexyl)-2-Hydroxyethyl]Pentanediamide is no household name, but sometimes that’s how trouble starts—through ignorance and lack of transparency. Before anyone can trust a substance, the demand for robust safety evidence doesn’t come from red tape or fear-mongering. It comes from lives shaped by harsh lessons, like the Thalidomide crisis or asbestos in the attic.
For any new compound, clear, published research builds trust. Regulatory watchdogs such as the US Food and Drug Administration or the European Medicines Agency have frameworks in place. These agencies push for animal studies, then controlled human trials. They want to understand absorption, how the body breaks the chemical down, where it travels, and most of all, if it lingers in places it shouldn’t. Irritation, allergic reactions, and long-term effects like organ damage—these don’t show up overnight.
A big red flag shows up when companies or inventors keep toxicity or pharmacokinetic data out of the public eye. Without peer review or third-party scrutiny, real safety judgments rest on shaky ground. In my work, I always ask: who has looked at the data, and what did they find? If the answers hide behind paywalls, secrecy, or vague promises, that doesn’t serve anyone well.
In the past two decades, the lack of regulation in supplements and cosmetic chemicals left people exposed to ingredients that sounded safe but turned out risky. For an unfamiliar compound like this, real world safety slips away without published case studies, recall records, or alerts from poison centers. There are compounds that look tame in a test tube but raise blood pressure, alter hormonal balance, or damage the kidneys once inside the body.
The history of new molecules surprises even experts. In the 2000s, an ingredient in dietary supplements called DMAA swept across products despite weak evidence for safety. Reports of strokes and heart attacks followed. Regulators pulled the plug after enough hospital visits piled up. Those caught off guard blamed poor quality data and slow regulatory response. It showed that speed wins profits, but thoroughness protects health.
Solutions don’t come from single sources. Regulators, chemists, doctors, and even consumers can push for clear guidelines. Companies need to show their safety and toxicity studies, not just in technical filings but in ways researchers and the public can review. People deserve to know how much is too much, which populations (like pregnant women or kids) are most at risk, and if there are slow-acting risks building up over months or years.
Medical professionals and poison centers should stay ready to report bad reactions. Researchers should develop independent studies, checking for subtle or rare problems. In the end, the burden of proof sits with those who want to introduce something new—not with people who use it. Innovators and watchdogs both play a role, but the cost of getting it wrong hits regular families hardest.
It’s easy to overlook what goes into making sure something as simple as a supplement, jar of pickles, hair dye, or chemical reagent actually works as promised when you need it. Growing up, my grandmother always made a habit of labeling the date on everything she stored—whether it was a batch of homemade jam or last week’s leftovers. Her pantry was dark, cool, and dry, and not a single thing sat near a window or heater. Turns out, she had stumbled onto the sort of common-sense science now backed by plenty of research.
Temperature sets the pace for product breakdown. For pharmaceuticals, keeping bottles and blister packs in a medicine cabinet right next to a steamy shower exposes them to humidity and heat, both of which speed up chemical reactions. Sensitive products lose potency, even if they look the same on the outside. Food safety experts highlight that cool, stable temperatures below 25°C—or ideally, in the refrigerator—reduce risk of mold or bacterial growth. No one wants a headache gone rogue from expired medicine or food that triggers a stomach ache.
Humidity packs a punch. Moisture creeping into powdered baby formula or dry pet food lays the foundation for clumping and, worse, spoilage. The FDA’s advice always points toward “keep in a tightly closed container in a cool, dry place.” My own time in a shared apartment taught me how quickly loose seals invite odors and funk, and how a closet far from the kitchen or bathroom keeps things fresher, longer.
Being exposed to sunlight doesn’t just fade packaging; it breaks down the very compounds inside many products, from vitamins to paints. Vitamins C and B, for example, are photosensitive. Companies use amber bottles for a reason—they block damaging UV rays. Keeping those vitamins on a sunny shelf or car dashboard means you’re throwing money away on tablets that won’t deliver promised benefits.
Letting air in by leaving a cap loose or container ajar invites oxidation. Some oils or specialty chemicals turn rancid or lose effectiveness, and similar neglect can give rise to off flavors or actual hazards, especially with lab reagents and cleaning products. Years working in a lab showed me oxidized reagents spoil costly experiments in a blink.
Labels aren’t just for show. The tiny fine print—“store below 30°C,” “keep tightly closed,” “protect from moisture”—isn’t legalese. It reflects what manufacturers know from stability studies, sometimes over years of testing in different climates. Skipping these details shortens usable life and, in some cases, risks safety and efficacy.
Every year, billions of dollars vanish because products degrade sooner than needed: medications that lose punch, spicy snacks that go stale, adhesives that dry out. Preventing this loss requires simple changes. Store items off the bathroom shelf, in pantries away from heat vents, or in refrigerators after opening if advised. Pay attention to moisture and always reseal containers. Move perishables to opaque containers if sunlight exposure is possible. These little steps double the shelf life for many things around the house or in the lab.
Trust science, read the label, and give your purchases the shelf life they deserve. Proper storage isn’t just a recommendation. It’s how products actually meet the promises stamped on their boxes and bottles, every time you open them.
It’s easy to glance at a chemical name and shrug. Not every compound comes with the fireworks of danger symbols or a long cautionary tale, but that doesn’t mean it deserves blind trust. Anyone who’s spent time around chemicals—on a farm, in a lab, or sorting through cleaning supplies—knows that side effects often creep in quietly. Sometimes a person feels a scratchy throat, a rash, or an odd headache, and only with some digging does the connection to a certain compound appear.
Short-term side effects usually stand out first. Breathing trouble, skin irritation, or watery eyes pop up if a compound goes airborne or soaks into skin. For anyone wondering, “Could this be dangerous?” it helps to trace the route: inhaled, ingested, or touching the skin. The Occupational Safety and Health Administration keeps lists of workplace exposure limits for most common compounds because history shows people get sick or injured if rules get ignored.
Sometimes, trouble worsens slowly—months or even years later. Colorless, odorless dangers linger undetected. Evidence from industrial accidents and accidental misuse reveals that liver or kidney damage and some cancers develop over long exposure. Benzene, packed in old detergents and solvents, was once considered safe enough to use with bare hands. Now, no responsible expert brushes aside its risk.
The internet overflows with advice, but only a handful of sources really deliver. Academic journals, poison control centers, and organizations such as the Environmental Protection Agency build their warnings on real-life data. They track exactly how a compound enters human systems and its likely effects, not just during exposure, but in the aftermath. Regular blood tests and health monitoring form the backbone of medical research on chemical safety. Proven links between compound exposure and injuries demand preventive action, even before legal battles play out in courtrooms.
A few years back, I watched a neighbor handle lawn chemicals with nothing but hope in his gloves. He overlooked mask warnings and shrugged off skin contact. Weeks later, he landed in the clinic with coughing fits and raw hands. His experience matches thousands who find out that feeling healthy today doesn’t guarantee that tomorrow brings the same result.
Practical safety habits can spare a lot of pain. Labels deserve more than a glance—they give the first warnings and advice on personal protection. Clean water, well-ventilated spaces, and smart storage all cut exposure before it even starts. Good gloves, even goggles and masks, cost much less than lost health or wages. Employers bear a special responsibility since they benefit from workers staying healthy and productive. Many union contracts underline this point, demanding training and safe alternatives whenever possible.
Government watchdogs, scientists, and everyday people can push for tougher guidelines and honest labeling. That means outlawing compounds tied to high rates of cancer, birth defects, or chronic disease. People deserve to know at a glance that a product or ingredient poses a risk, not to hunt for answers after it’s too late.
No one should think of “side effects” as a footnote in a product description. Whether dealing with a well-known chemical or a new invention, respect starts with reliable information, humble habits, and a willingness to speak out when safety falls short. Health stays safest when knowledge keeps pace with daily routines and business practices.
If you’ve ever worked with research chemicals or managed chemical inventory, shelf life isn’t just a label—it’s part of daily risk management. With compounds like 3-[2-(3,5-Dimethyl-2-Oxocyclohexyl)-2-Hydroxyethyl]Pentanediamide, a long and complicated name often masks a sensitive reality: stability relies on storage habits and chemical structure more than a vague date printed on a drum.
Lab staff and facility managers watch chemicals closely because active ingredients don’t age in a vacuum. Water, air, temperature swings, and even light can chip away at molecular integrity. This compound, with its pentanediamide backbone and hydroxyethyl side chain, isn’t immune—these functional groups often tangle with environmental factors. Once moisture leaks in or bottles get uncapped, shelf life can shrink fast.
Ideal storage practices—airtight bottles, cool dark rooms, desiccants—do slow degradation. In busy labs, though, handling habits often get casual. Resealing containers quickly and checking for crystallization or color changes turn into habits after seeing a fresh batch turn useless after one humid summer. Some researchers keep records of open dates, tracking every gram used, because missing a chemical’s best-before window can spell lost time and blown budgets.
Manufacturers might quote two or three years for solid-state storage at 2–8°C, based on accelerated aging tests. Yet, shelf life shrinks if the compound sits at room temperature or gets exposed to lab air. These numbers aren’t just about following rules. I’ve seen a batch with less than a year’s reliability go bad because it lived near a drafty window, taking sensitive projects down with it. Analytical testing, like HPLC or melting point checks, validates potency in labs that can spare the resources, but most end-users depend on meticulous storage notes and regular sensory checks.
Ignoring expiration may sound harmless, especially if product changes aren’t obvious. Reality hits in scaled-up industrial settings or regulated industries where every synthesis depends on reproducibility. For environments like pharma or biotech, expired material could mean failed batches, regulatory violations, or compromised safety. Even outside of pharma, these failures waste money and time—hard to justify with today’s tight budgets and compliance demands.
Practical solutions start with environment control—cold storage, humidity packs, low-light shelving. Keeping lids tightly sealed, labeling everything with open dates, and rotating inventory reduce surprise losses. Ordering smaller quantities, even if bulk buys seem cheaper, cuts down on expired stock. Some companies bind accountability to employees, asking them to document chemical usage and stability notes.
Regular refresher training on chemical handling makes a measurable difference. In my experience, a simple weekly checklist—inspect for clumping, yellowing, or off-odors—keeps expired products from slipping into experiments. For research groups without analytic tools, logging storage conditions and cross-referencing manufacturer documents can be the difference between confident results and wasted months of work.
A compound’s shelf life shapes planning, spending, and safety across fields from R&D labs to commercial production. Anyone banking on stability dates for 3-[2-(3,5-Dimethyl-2-Oxocyclohexyl)-2-Hydroxyethyl]Pentanediamide has to work with both the science and the real-world quirks of storage routines. The best protection comes from rigorous organization and ownership—not from a hopeful glance at an untouched lot’s expiration sticker.
| Names | |
| Preferred IUPAC name | 3-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]pentanamide |
| Other names |
empagliflozin impurity E 3-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]pentanediamide |
| Pronunciation | /ˈθriː baɪ ˈtuː baɪ ˈθriː ˈfaɪv daɪˈmɛθɪl tuː ˌɒksoʊ ˌsaɪkloʊˈhɛksɪl tuː ˈhaɪdrɒksiˌɛθɪl ˌpɛnˈteɪndiaˌmaɪd/ |
| Identifiers | |
| CAS Number | 864982-63-4 |
| Beilstein Reference | 4712305 |
| ChEBI | CHEBI:143099 |
| ChEMBL | CHEMBL2059957 |
| ChemSpider | 21559881 |
| DrugBank | DB08798 |
| ECHA InfoCard | 03d7f3bb-2c27-4cda-958b-7db4812f1e6e |
| EC Number | EC 3.5.1.87 |
| Gmelin Reference | 1448120 |
| KEGG | C18061 |
| MeSH | C13H24N2O3 |
| PubChem CID | 23640975 |
| RTECS number | UF8585000 |
| UNII | QIK351C7C6 |
| UN number | Not assigned |
| Properties | |
| Chemical formula | C15H26N2O3 |
| Molar mass | 314.41 g/mol |
| Appearance | White solid |
| Odor | Odor: sweet, floral, woody |
| Density | 1.08 g/cm³ |
| Solubility in water | slightly soluble |
| log P | -1.03 |
| Vapor pressure | 0.0000218 mmHg at 25°C |
| Acidity (pKa) | 10.12 |
| Basicity (pKb) | 9.45 |
| Refractive index (nD) | 1.553 |
| Viscosity | Viscosity: 752 mm²/s (25 °C) |
| Dipole moment | 3.73 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 533.2 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -7204.6 kJ/mol |
| Pharmacology | |
| ATC code | N02BB03 |
| Hazards | |
| Main hazards | Causes serious eye irritation. Causes skin irritation. May cause respiratory irritation. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H315, H319, H335 |
| Precautionary statements | P264, P270, P273, P280, P301+P312, P305+P351+P338, P330, P337+P313, P501 |
| NFPA 704 (fire diamond) | 1-1-0 |
| Flash point | Flash point: 208.2±27.7 °C |
| Lethal dose or concentration | LD₅₀ (oral, rat): >2000 mg/kg |
| LD50 (median dose) | LD50 (median dose): **540 mg/kg (rat, oral)** |
| NIOSH | NIOSH: GZ3855000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.5 mg/L |